Master dataINID | Criterion | Field | Content |
---|
| Type of IP right | SART | Protection certificate |
| Status | ST | Pending/in force |
21 | DE file number | DAKZ | 12 2011 100 047.1 |
| Use | VZ | Medicinal products |
95 | Product name | TIEZ | Fingolimod oder ein pharmazeutisch akzeptables Salz hiervon |
54 | Title of basic patent | TIGZ | FESTE PHARMAZEUTISCHE DARREICHUNGSFORMEN MIT EINEM S1P REZEPTORAGONISTEN UND EINEM ZUCKERALKOHOL |
51 | IPC main class | ICM (ICMV) | A61K 9/20 (2006.01) |
51 | IPC secondary class(es) | ICS (ICSV) | A61K 9/48 (2006.01) |
94 | Start of term of protection | LB | Apr 7, 2024 |
94 | End of term of protection | LE | Mar 22, 2026 |
22 | DE application date | DAT | Sep 8, 2011 |
| Date of publication of application for a certificate | OT | Dec 15, 2011 |
| Date of publication of grant of certificate | PET | Oct 29, 2020 |
71/73 | Applicant/owner | INH | Mitsubishi Tanabe Pharma Corporation, 2-6-18 Kitahama, Chuo-ku, 541-8505 Osaka, JP; Novartis AG, Lichtstr. 35, 4056 Basel, CH |
74 | Representative | VTR | Breuer, Markus, Dr., 80331 München, DE |
| Address for service | | Breuer, Markus, Dr., 80333 München, DE |
| Patent division in charge | | 44 |
68 | DE file number of basic patent | GAKZ | 60 2004 017 847.0 |
68 | EP file number of basic patent | GEAKZ | 04 72 5895.9 |
43 | Date of first publication | EVT | Dec 15, 2011 |
92 92 92
| Domestic authorisation | GIS GIN GIT
| Europäische Kommission EU /1/11/677/002 2011-03-17
|
92 92 92
| Domestic authorisation | GIS GIN GIT
| Europäische Kommission EU/1/11/677/004 2011-03-17
|
92 92 92
| Domestic authorisation | GIS GIN GIT
| Europäische Kommission EU /1/11/677/001 2011-03-17
|
92 92 92
| Domestic authorisation | GIS GIN GIT
| Europäische Kommission EU/1/11/677/003 2011-03-17
|
93 93 93 93
| EU authorisation | GES GEC GEN GET
| Europäische Kommission EU EU/1/11/677/003 2011-03-17
|
93 93 93 93
| EU authorisation | GES GEC GEN GET
| Europäische Kommission EU EU/1/11/677/002 2011-03-17
|
93 93 93 93
| EU authorisation | GES GEC GEN GET
| Europäische Kommission EU EU/1/11/677/004 2011-03-17
|
93 93 93 93
| EU authorisation | GES GEC GEN GET
| Europäische Kommission EU EU/1/11/677/001 2011-03-17
|
| Date of the first transfer into DPMAregister | EREGT | Dec 15, 2011 |
| Date of the (most recent) update in DPMAregister | REGT | Apr 2, 2025 (Show all update days)(Hide all update days)- Apr 2, 2025
- Aug 14, 2024
- St.36: changed (technical change)
- Apr 11, 2024; Mar 13, 2024; Feb 5, 2022; Oct 28, 2020; Sep 22, 2020; Jul 21, 2020; Oct 10, 2019; Sep 6, 2019; Jul 16, 2019; May 26, 2018; Oct 21, 2017; Jul 7, 2017; Dec 10, 2016; Oct 3, 2015; Aug 25, 2015; Jul 11, 2015; Sep 24, 2013; Mar 16, 2013; Feb 6, 2013; Dec 7, 2012; Oct 12, 2012; Oct 10, 2012; Oct 9, 2012; Jun 22, 2012; Jun 19, 2012
- Historical data not available for this/these date(s)
- Dec 15, 2011
- Date of the first transfer into DPMAregister
|
View procedures New applicant/owner details (No.: 2)INID | Criterion | Field | Content
Close details
|
---|
| Type of procedure | VART | New applicant/owner details |
| Legal/procedural status | VST | New applicant/owner details |
| Date of legal/procedural status | VSTT | Oct 24, 2011 |
71/73 | Applicant/owner | INH | Mitsubishi Tanabe Pharma Corporation, 541-8505 Osaka, JP; Novartis AG, 4056 Basel, CH |
71/73 | Previous applicant/owner | INHF | Mitsubishi Tanabe Pharma Corporation, 541-8505 Osaka, Osaka-shi, JP, Novartis AG, 4056 Basel, CH |
View procedures New representative details (No.: 3)INID | Criterion | Field | Content
Close details
|
---|
| Type of procedure | VART | New representative details |
| Legal/procedural status | VST | New representative details |
| Date of legal/procedural status | VSTT | Sep 5, 2019 |
74 | Representative | VTR | Breuer, Markus, Dr., 80331 München, DE |
74 | Previous representative | VTRF | Henkel & Partner mbB Patentanwaltskanzlei, Rechtsanwaltskanzlei, 80333 München, DE |
| Date of update of the procedure | REGT | Mar 13, 2024 |